| 6LUD | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| ligand | YY3 | enzyme |
| ||||||||||||
| Primary reference | CH7233163 overcomes osimertinib resistant EGFR-Del19/T790M/C797S mutation., Kashima K, Kawauchi H, Tanimura H, Tachibana Y, Chiba T, Torizawa T, Sakamoto H, Mol Cancer Ther. 2020 Sep 17. pii: 1535-7163.MCT-20-0229. doi:, 10.1158/1535-7163.MCT-20-0229. PMID:32943545 | ||||||||||||||
| Data retrieval |
![]() |
| View 6LUD in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |